SGLT2i for Mitral Regurgitation; Mining Angiograms With AI; Melatonin and CVD Risk?
Med Page Today
MAY 7, 2024
Mashable) The SGLT2 inhibitor ertugliflozin (Steglatro) showed promise for the reduction of functional mitral. (MedPage Today) -- The Apple Watch atrial fibrillation feature got added to FDA's list of qualified devices for use in clinical studies.
Let's personalize your content